This inventor holds 1 USPTO granted patent. Top assignees: Mayo Foundation for Medical Education and Research, University of Leeds. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019
Title: Rosa Maria Diaz: Innovator in Cancer Treatment
Introduction
Rosa Maria Diaz is a prominent inventor based in Rochester, MN (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on developing effective strategies for combating cancer, particularly through the use of specific antigens.
Latest Patents
Rosa Maria Diaz holds a patent for "Methods and materials for treating cancer." This patent outlines various methods and materials designed to treat cancer using combinations of antigens. For instance, her research includes the use of VSV vectors that express GNAQ, TYRP1, and N-RAS antigens to reduce the number of cancer cells, such as uveal melanoma cells, in mammals, including humans. Additionally, her work explores the application of VSV vectors expressing BRAF, TOPO-11a, and YB-I antigens to target skin melanoma cells. The composition described in her patent can comprise less than 50 separate nucleic acid molecules.
Career Highlights
Throughout her career, Rosa Maria Diaz has been associated with esteemed institutions such as the Mayo Foundation for Medical Education and Research and the University of Leeds. Her dedication to advancing cancer treatment has positioned her as a key figure in medical research.
Collaborations
Rosa has collaborated with notable colleagues, including Jose S Pulido and Richard G Vile, who have contributed to her research endeavors.
Conclusion
Rosa Maria Diaz's innovative work in cancer treatment exemplifies her commitment to improving healthcare outcomes. Her patented methods and collaborations highlight her significant impact in the field of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile